Krishna Ella makes a pitch to remove GST on millets - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.
New Delhi: Swiss biologics contract development and manufacturing organisation ExcellGene SA on Tuesday said it has partnered with Bharat Biotech and the University of Sydney to develop a.
Ocugen (OCGN) said interim data from phase 2/3 trial of Covaxin, developed by India's Bharat Biotech, was published in a journal and mentioned that the COVID-19 vaccine showed efficacy.
Get latest articles and stories on India at LatestLY. Bharat Biotech International Ltd (BBIL) on Tuesday said its COVID-19 vaccine, Covaxin, has received emergency use approval in children 6-12 years of age in India. India News | Bharat Biotech s Covaxin Gets Emergency Approval for 6-12 Age Group.